APC’s Board this week approved minor revisions to its policy statement on Constructive Transfer of compounded controlled substance drugs. The statement was first adopted in 2010.
APC is releasing to its Pharmacy/Facility Members this week a Primer on Compounding Accreditations to assist them in determining accreditations they may wish to pursue.
APC’s Board of Directors has authorized two “best practices” documents aimed at helping APC members practice with utmost care and consistency.
Community pharmacies — defined as any pharmacy that dispenses medication to an outpatient, including both resident and nonresident pharmacies — are now required to report medication errors in California.
Through the generosity of Pharmacists Mutual Insurance Company, the Pharmacy Compounding Foundation is offering up to two (2) pharmacy students a scholarship valued at $2,500.
Before APC determines its position and prepares comments to FDA on the proposed rule, we want to hear from you.
If you haven’t read it yet, an excellent commentary was published in Medscape this week by a cardiologist and obesity specialist. He pushes back against rampant misinformation around compounded GLP-1s.
It’s been breathlessly anticipated for months, and this week it finally published: an FDA proposed rule regarding the Demonstrably Difficult to Compound list.
Since the program’s inception in 1997, 162 professionals have been honored as APC Fellows.
Long-time APC supporter Wedgewood Pharmacy, a compounder focused exclusively on animal health, is our newest 2024 Silver-level Corporate Patron.
FOLLOW US
